Corticosteroids remain an important treatment option, while some targeted therapies may be appropriate for individuals with specific genetic variants. Physical therapy, stretching, respiratory monitoring, cardiac care, nutritional support, and regular assessments are also important. Treatment plans are individualized according to age, symptoms, genetic findings, functional abilities, and overall health.
Duchenne muscular dystrophy (DMD) is a genetic disorder that causes progressive muscle weakness, most commonly affecting boys. It results from changes in the DMD gene, which provides instructions for producing dystrophin, a protein that helps maintain muscle fibers. Although there is currently no universal cure, advances in treatment have expanded options for managing symptoms and complications. Early diagnosis and coordinated care can help preserve physical function and address heart, respiratory, bone, and nutritional concerns.
Treatment is generally individualized and may combine medicines, rehabilitation, monitoring, and supportive care. Corticosteroids such as prednisone or deflazacort may help maintain muscle strength and prolong mobility in many people with DMD. Some newer therapies are designed for particular genetic changes and are appropriate only for eligible patients.
Common treatment approaches include:
Corticosteroid therapy: May slow the progression of muscle weakness and help maintain mobility.
Genetic therapies: Certain treatments may be considered for specific DMD mutations and patient characteristics.
Physical therapy: Gentle stretching and appropriate physical activity can help maintain flexibility and reduce the risk of contractures.
Cardiac care: Regular heart assessments are important because DMD can affect the heart muscle.
Respiratory care: Lung function may be monitored as muscle weakness progresses, with breathing support used when clinically appropriate.
Bone health management: Vitamin D, calcium assessment, mobility support, and monitoring may help address osteoporosis and fracture risk.
Treatment decisions should be made with qualified healthcare professionals because medicines and rehabilitation strategies can have different benefits and risks depending on the individual.
Long-term management involves regular monitoring because DMD can affect several body systems over time. A multidisciplinary care team can coordinate neurological, cardiac, respiratory, orthopedic, nutritional, and psychological support. Assistive devices, mobility equipment, and adaptations at home or school may also help individuals remain as independent as possible.
Important aspects of ongoing management include:
Regular neurological and functional assessments.
Routine cardiac evaluations and appropriate heart treatment.
Periodic respiratory testing and evaluation for sleep related breathing problems.
Stretching and positioning programs to help preserve joint movement.
Monitoring nutrition, weight, bone health, and swallowing difficulties.
Emotional, educational, and social support for the individual and family.
Genetic counseling to explain inheritance patterns and family testing options.
Because DMD changes over time, treatment plans may need to be adjusted as mobility, respiratory function, cardiac health, and daily needs change. Early attention to new symptoms can help healthcare professionals respond appropriately.
Overall, Duchenne muscular dystrophy management combines disease modifying treatments where appropriate with rehabilitation and supportive medical care. Regular follow up and coordinated multidisciplinary treatment can help address complications, maintain function, and support quality of life. Treatment options continue to develop, making individualized medical guidance important for people living with DMD and their families.